Skip to contentW
Windtree Therapeutics Inc
W
WINTWindtree Therapeutics Inc Q1 2017 · 10-Q
Revenue$219.00K$219.00K+192.0% vs Q1 2016 Net Income-$8.72M-$8.72MN/M vs Q1 2016 EPS Diluted-$27.40-$27.40N/M vs Q1 2016 Operating Income-$8,116,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR
Free Cash Flowderived-$7,352,000N/M Margins · derivedOperating margin-3705.9%+14883.4 pt vs Q1 2016
Net margin-3983.6%+14551.1 pt vs Q1 2016
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end